These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29432993)

  • 1. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
    Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
    Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
    Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
    Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y
    Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells.
    Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Integr Cancer Ther; 2014 May; 13(3):NP18-28. PubMed ID: 22505597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma
    Song M; Liu X; Liu K; Zhao R; Huang H; Shi Y; Zhang M; Zhou S; Xie H; Chen H; Li Y; Zheng Y; Wu Q; Liu F; Li E; Bode AM; Dong Z; Lee MH
    Mol Cancer Ther; 2018 Jul; 17(7):1540-1553. PubMed ID: 29695636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
    Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
    Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
    Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.
    Liu H; Qian C; Shen Z
    Tumour Biol; 2014 Sep; 35(9):9139-46. PubMed ID: 24916572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
    BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.
    Hu HZ; Yang YB; Xu XD; Shen HW; Shu YM; Ren Z; Li XM; Shen HM; Zeng HT
    Acta Pharmacol Sin; 2007 Nov; 28(11):1819-26. PubMed ID: 17959034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.